Clinical Trials

Inclusion Criteria: 

• Adult patients ≥ 18 years of age and ≤ 85 years of age.
• Nodule with Papillary thyroid carcinoma meeting the below criteria: 
  • Diagnosed by FNA cytology;
  • Size < 1.5 cm;
  • Non-surgical therapy is considered acceptable by the treating physician;
  • Radiology evaluation deems the lesion amenable to RFA therapy with minimal risk of complication.

Exclusion Criteria: 

• Clinical evidence for a multifocal papillary thyroid malignancy.
• Clinical evidence for local or distant metastatic disease. 
• Pregnancy.
• Vocal cord paralysis on contralateral side. 
• Coagulopathy or patients on anticoagulation therapy.
• Patients with prior neck surgery or neck radiation. 
• Patients with neck anatomy that precludes easy access by RFA. 
• Patients with comorbidities deemed too high of a risk for general anesthesia.
• Treatment with another investigational drug or intervention (within 6 weeks of planned RFA). 
• Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.